| Code | 7675E | ||||||||||
| MA number | 31/0261/24-S | ||||||||||
| Product Form: | tbl flm 100x1x10 mg/10 mg (blis.OPA/Al/PVC//Al - jednotk.bal.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 09.10.2024 |
| Validity: | 09.10.2029 |
| SPC: |
SPC_Ezetimib_Atorvastatín Sandoz_10_2024.pdf
|
| PIL: |
PIL_Ezetimib-Atorvastatín Sandoz_10.2024.pdf
|
| Safety feature | Yes |
| Data update: | 10.10.2024 |
